182 related articles for article (PubMed ID: 37680562)
1. Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular events.
Le VT; Knight S; Watrous JD; Najhawan M; Dao K; McCubrey RO; Bair TL; Horne BD; May HT; Muhlestein JB; Nelson JR; Carlquist JF; Knowlton KU; Jain M; Anderson JL
Front Cardiovasc Med; 2023; 10():1229130. PubMed ID: 37680562
[TBL] [Abstract][Full Text] [Related]
2. Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial.
Myhre PL; Kalstad AA; Tveit SH; Laake K; Schmidt EB; Smith P; Nilsen DWT; Tveit A; Solheim S; Arnesen H; Seljeflot I
J Intern Med; 2022 May; 291(5):637-647. PubMed ID: 34982486
[TBL] [Abstract][Full Text] [Related]
3. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G
Eur J Prev Cardiol; 2024 Jun; ():. PubMed ID: 38869144
[TBL] [Abstract][Full Text] [Related]
4. n-3 fatty acids and cardiovascular events after myocardial infarction.
Kromhout D; Giltay EJ; Geleijnse JM;
N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341
[TBL] [Abstract][Full Text] [Related]
5. Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary prevention.
Alfaddagh A; Kapoor K; Dardari ZA; Bhatt DL; Budoff MJ; Nasir K; Miller M; Welty FK; Miedema MD; Shapiro MD; Tsai MY; Blumenthal RS; Blaha MJ
Atherosclerosis; 2022 Jul; 353():11-19. PubMed ID: 35759823
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials.
Casula M; Olmastroni E; Gazzotti M; Galimberti F; Zambon A; Catapano AL
Pharmacol Res; 2020 Oct; 160():105060. PubMed ID: 32634581
[TBL] [Abstract][Full Text] [Related]
7. Serum n-3 and n-6 polyunsaturated fatty acid profile as an independent predictor of cardiovascular events in hemodialysis patients.
Shoji T; Kakiya R; Hayashi T; Tsujimoto Y; Sonoda M; Shima H; Mori K; Fukumoto S; Tahara H; Shioi A; Tabata T; Emoto M; Nishizawa Y; Inaba M
Am J Kidney Dis; 2013 Sep; 62(3):568-76. PubMed ID: 23602192
[TBL] [Abstract][Full Text] [Related]
8. An omega-3 fatty acid plasma index ≥4% prevents progression of coronary artery plaque in patients with coronary artery disease on statin treatment.
Alfaddagh A; Elajami TK; Saleh M; Mohebali D; Bistrian BR; Welty FK
Atherosclerosis; 2019 Jun; 285():153-162. PubMed ID: 31055222
[TBL] [Abstract][Full Text] [Related]
9. Effect of eicosapentaenoic acid/docosahexaenoic acid on coronary high-intensity plaques detected with non-contrast T1-weighted imaging (the AQUAMARINE EPA/DHA study): study protocol for a randomized controlled trial.
Nakao K; Noguchi T; Asaumi Y; Morita Y; Kanaya T; Fujino M; Hosoda H; Yoneda S; Kawakami S; Nagai T; Nishihira K; Nakashima T; Kumasaka R; Arakawa T; Otsuka F; Nakanishi M; Kataoka Y; Tahara Y; Goto Y; Yamamoto H; Hamasaki T; Yasuda S
Trials; 2018 Jan; 19(1):12. PubMed ID: 29310688
[TBL] [Abstract][Full Text] [Related]
10. Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial.
de Borst MH; Baia LC; Hoogeveen EK; Giltay EJ; Navis G; Bakker SJL; Geleijnse JM; Kromhout D; Soedamah-Muthu SS
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29137111
[TBL] [Abstract][Full Text] [Related]
11. Marine n-3 Polyunsaturated Fatty Acids and the Risk of Ischemic Stroke.
Venø SK; Bork CS; Jakobsen MU; Lundbye-Christensen S; McLennan PL; Bach FW; Overvad K; Schmidt EB
Stroke; 2019 Feb; 50(2):274-282. PubMed ID: 30602356
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study.
Dunbar RL; Gaudet D; Davidson M; Rensfeldt M; Yang H; Nilsson C; Kvarnström M; Oscarsson J
Lipids Health Dis; 2020 May; 19(1):117. PubMed ID: 32473640
[TBL] [Abstract][Full Text] [Related]
13. Association between the ratio of serum eicosapentaenoic acid to arachidonic acid and risk of coronary artery disease in young Chinese patients.
Liu X; Sun L; Wen W; Qiu M; Luo J; Li W; Hao S; He M; Wu J; Hu Y; Huang Y
Front Nutr; 2022; 9():1019058. PubMed ID: 36407537
[TBL] [Abstract][Full Text] [Related]
14. Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH Trial.
Nissen SE; Lincoff AM; Wolski K; Ballantyne CM; Kastelein JJP; Ridker PM; Ray KK; McGuire DK; Mozaffarian D; Koenig W; Davidson MH; Garcia M; Katona BG; Himmelmann A; Loss LE; Poole M; Menon V; Nicholls SJ
JAMA Cardiol; 2021 May; 6(8):1-8. PubMed ID: 33993205
[TBL] [Abstract][Full Text] [Related]
15. Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis.
Khan SU; Lone AN; Khan MS; Virani SS; Blumenthal RS; Nasir K; Miller M; Michos ED; Ballantyne CM; Boden WE; Bhatt DL
EClinicalMedicine; 2021 Aug; 38():100997. PubMed ID: 34505026
[TBL] [Abstract][Full Text] [Related]
16. Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study.
Mozaffarian D; Lemaitre RN; King IB; Song X; Huang H; Sacks FM; Rimm EB; Wang M; Siscovick DS
Ann Intern Med; 2013 Apr; 158(7):515-25. PubMed ID: 23546563
[TBL] [Abstract][Full Text] [Related]
17. Dietary and Circulating Long-Chain Omega-3 Polyunsaturated Fatty Acids and Mortality Risk After Myocardial Infarction: A Long-Term Follow-Up of the Alpha Omega Cohort.
Pertiwi K; Küpers LK; de Goede J; Zock PL; Kromhout D; Geleijnse JM
J Am Heart Assoc; 2021 Dec; 10(23):e022617. PubMed ID: 34845924
[TBL] [Abstract][Full Text] [Related]
18. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
Martins JG
J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
[TBL] [Abstract][Full Text] [Related]
19. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
20. Which has the stronger impact on coronary artery disease, eicosapentaenoic acid or docosahexaenoic acid?
Iwamatsu K; Abe S; Nishida H; Kageyama M; Nasuno T; Sakuma M; Toyoda S; Inoue T
Hypertens Res; 2016 Apr; 39(4):272-5. PubMed ID: 26739870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
